# Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma

> **NCT00057954** · PHASE2 · TERMINATED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 6 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **PROCEDURE:** Extracorporeal Photopheresis
- **DRUG:** Pentostatin
- **RADIATION:** Total body irradiation (TBI)
- **PROCEDURE:** Allogeneic bone marrow transplantation
- **DRUG:** Cyclosporin (CSA)
- **DRUG:** Mycophenolate mofetil (MMF)
- **DRUG:** Methotrexate (MTX)

## Key facts

- **NCT ID:** NCT00057954
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-11-09
- **Primary completion:** 2008-04
- **Final completion:** 2011-05
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2023-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00057954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00057954, "Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00057954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*